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Ghrelin,  an  endogenous  ligand  of  the  growth  hormone  secretagogue  receptor  (GHS-R),  has  been  sug-
gested  to be associated  to  obesity,  insulin  secretion,  cardiovascular  growth  and  homeostasis.  GHS-R  has
been  found  in most  of the  tissues,  and  among  the hormone  action  it is included  the  regulation  of  heart
energy  metabolism.  Therefore,  hypernutrition  during  early  life  leads  to  obesity,  induces  cardiac  hyper-
trophy,  compromises  myocardial  function,  inducing  heart failure  in  adulthood.  We  examined  ghrelin
signaling  process  in  cardiac  remodeling  in these  obese  adult  mice.  The  cardiomyocytes  (cmy)  of left  ven-
tricle  were  analyzed  by light  microscopy  and  stereology,  content  and  phosphorilation  of  cardiac  proteins:
ghrelin  receptor  (growth  hormone  secretagogue  receptor  1a,  GHSR-1a),  protein  kinase  B (AKT  and  pAKT),
phosphatidil  inositol  3 kinase  (PI3K),  AMP-activated  protein  kinase  (AMPK  and  pAMPK)  and  actin  were
achieved  by  Western  blotting.  GHSR-1a  gene  expression  was  analyzed  by  Real Time-PCR.  We observed
hyperglycemia  and  higher  liver  and  visceral  fat weight  in  obese  when  compared  to  control  group. Obese
mice presented  a marked  increase  in heart  weight/tibia  length,  indicating  an  enlarged  heart  size or  a
remodeling  process.  Obese  mice  had  increased  GHSR-1a  content  and  expression  in  the heart  associated
to  PI3K  content  and  increased  AKT  content  and phosphorylation.  In contrast,  AMPK  content  and  phospho-
rylation  in heart  was  not  different  between  experimental  groups.  Ghrelin  plasma  levels  in  obese  group
were decreased  when  compared  to  control  group.  Our  data  suggest  that  remodeled  myocardial  in  adult
obese  mice  overnourished  in  early  life  are  associated  with  higher  phosphorylation  of  GHSR-1a,  PI3K  and
AKT but  not  with  AMPK.. Introduction
Obesity in early life causes cardiovascular disease and type 2 dia-
etes in adulthood [4,7,11,51].  For instance, it is well established
hat heart development is sensitive to nutrition and hormonal
hanges during early life [28,51].  Results from the literature showed
hat obesity in early life leads to cardiac hypertrophy mainly
ue to increased cell size and protein synthesis. Consequently,
he development of myocardial energy metabolism and function
mpairment is associated with heart failure in adulthood. For
nstance, recent data from our group showed association between
nsulin signaling cascade impairment and cardiac hypertrophy in
bese rats overnourished in early life [26,28].
Ghrelin is a 28-amino acid peptide released from the stom-
ch bound to the endogenous ligand for the growth hormone
ecretagogue receptor (GHS-R) [22]. This hormone has been asso-
iated with several metabolic processes in different tissues. The
ost widely known functions of ghrelin are the ability to increase
∗ Corresponding author. Tel.: +55 21 2587 6407; fax: +55 21 2587 6129.
E-mail address: asmoura@nebin.org (A.S. Moura).
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GH secretion and stimulatory effect on food intake and adipos-
ity [10], despite the fact that ghrelin has been found reduced in
obese individuals when compared to lean subjects [8]. This hor-
mone has also been associated with modulation of metabolism in
different tissues, including the heart. Ghrelin which was initially
described in the hypothalamus, has been found in rat ventricles,
atria, aorta, coronary and carotid arteries [13]. Different authors
suggest that ghrelin may  have an autocrine/paracrine function in
cardiovascular tissues mainly associated with myocardial contrac-
tility, vasodilatation, and anti-inﬂammatory effects. In addition,
the cardiovascular action of the peptide in obese patients includes
decreasing of blood pressure through central mechanisms and
increasing of cardiac output without affecting heart rate. The direct
vascular actions of ghrelin are diverse and seem to differ between
species and vasculature of different organs. In clinical investi-
gations ghrelin showed vasodilator characteristic: it increased
forearm blood ﬂow when given intraarterially [32] and reversed
the constrictor effect of endothelin-1 (ET-1) in vitro on endothelium
Open access under the Elsevier OA license.human mammary artery rings [20,52] and also induced vasodila-
tion in phenylephrine-constricted perfused rat mesenteric vascular
bed [27]. Indeed, vasoconstrictor effect of the ghrelin was stud-
ied, researchers found tone-dependent vasoconstrictor effect of
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hrelin on human mesenterial and guinea-pig renal and femoral
rterioles only when vessels were previously stimulated with ET-1
14,18,33–35].
It has been suggested that by restoring plasma ghrelin lev-
ls the organism may  obtain cardiovascular protective effects as
ilate peripheral blood vessels, constrict coronary artery, improve
ndothelial function, as well as inhibit myocardial cell apoptosis
56]. For instance, acylated ghrelin is positively associated with sys-
olic blood pressure and left ventricular mass indices, even after
orrection for body mass index (BMI), suggesting that increased
hrelin concentrations could be a compensatory mechanism to
vercome the development of hypertension and left ventricular
ypertrophy in patients with metabolic syndrome [38,47].
Concerning the signaling process of the hormone, it has been
emonstrated that modulates the activation of AKT, protein
nvolved in postnatal cardiac growth and coronary angiogenesis
19], time-dependently and is associated to PI3K and AMPK phos-
horylation, protein kinases that have central role in the signaling
rocesses for energy metabolism and cell growth [2,3,6,23].
In this paper we hypothesized that obesity and heart hypertro-
hy caused by early life overnutrition could be related to changes
n ghrelin signaling in heart, mainly in ghrelin-associated proteins
AKT, PI3K and AMPK), inducing a new pattern of heart growth or
emodeling and heart energetic availability.
. Experimental methods
.1. Animals and treatments
Virgin female Swiss mice were time crossed at 3 months of age.
uring pregnancy and lactation, they were singly housed in indi-
idual cages and had ad libitum water and a standard pellet diet.
fter birth, litters were adjusted to nine pups per dam. At postna-
al day 3, to induce early postnatal overnutrition, the number of
ups per dam was adjusted to three male mice per litter to form
he small litter (SL) [35], whereas litters containing nine pups per
other served as controls (normal litter (NL). To complete sample
ize only one male mice of each litter was used in order to dis-
ard pups of the same litter [48]. After weaning at postnatal day
1, mice were housed with three mice per cage with free access
o water and standard chow in a temperature-controlled room
ith a 12 h light:12 h darkness cycle. They were weighed weekly
nd were killed at 180 days of age. Before the sacriﬁce mice were
asted overnight, injected with heparin (5000 U/kg), and then anes-
hetized with Avertin (0.3 g/kg body weight, via i.p. injection). They
ere cared for in accordance with the Animal Care and Use Com-
ittee of the Biology Institute of the State University of Rio de
aneiro, which based its analysis on the principles described in the
uide for Care and Use of Laboratory Animals [5].
.2. Blood collection
After a 12-h fast, blood glucose concentration was  measured
rom blood droplets removed from the tail vein of 180 day old SL
nd age-matched NL mice with a glucometer (Accu-Chek, Roche,
ao Paulo, Brazil).
Acylated ghrelin levels were determined in plasma using a com-
ercial assay kit (Millipore, ELISA Kit, Rat/Mouse Ghrelin active).
lood sample was obtained under anesthesia by heart puncture,
ollected into a centrifuge tube containing K3 EDTA to achieve a
nal concentration of 1.735 mg/mL  and treated with Pefabloc fol-
owed by immediate centrifugation (3000 rpm for 10 min  at 4 ◦C).
lasma samples were acidiﬁed with HCl to a ﬁnal concentration of
.05 N and stored at −20 ◦C until assayed.ptides 35 (2012) 65–73
2.3. Visceral fat measurement
Fat deposits (retroperitoneal and epididymal) were completely
removed from both sides of the animal and weighed on an analyt-
ical balance.
2.4. Estimation of heart and liver volume
The volume of the entire heart were harvested and weighed on
an analytical scale. The volume of liver and heart was determined
according to the submersion method in which the water displace-
ment (in isotonic saline), the organ volume (V) was recorded by
weighing (W). As the isotonic saline speciﬁc density (d) is 1.0048,
the respective volumes were obtained by V [organ] (cm3) = W (g)/d
or simply V (103 cm3) ( W (g) [49].
2.5. Heart analyses
Soon after killing the animals at 180 days of age, their hearts
were harvested and weighed on an analytical scale. One leg was
removed above the knee joint and the muscle and the skin around
the tibias were dissected. The length of the tibias from the condyles
to the tip of the medial malleolus was  measured by microme-
ter calipers. The heart size was  evaluated by analyzing the heart
weight/tibia length ratio [55].
The heart fragments were ﬁxed for 48 h in the ﬁxative (freshly
prepared 4% (w/v) formaldehyde in 0.1 M phosphate buffer pH 7.2).
After embedding in Paraplast Plus (Sigma–Aldrich, St. Louis, MO,
USA) and sliced into 3 m thick sections; the sections were stained
with hematoxylin and eosin.
The stereological analyses were performed using a Leica DMRBE
microscope (Wetzlar, Germany), a Kappa video camera (Gle-
ichen, Germany) and a Sony Trinitron monitor (Pencoed, UK).
The myocardium was  analyzed by considering the cardiomyocytes
[cmy] and the intramyocardial arteries [ima].
The volume density (Vv) was  estimated by point counting
for cardiomyocytes (cmy) and intramyocardial arteries (ima):
Vv[structure] = PP[structure]/PT. Where PP is the number of points
that hit the structure, and PT is the total test points.
The amount of intramyocardial vascularization was estimated
as the Vv[ima]/Vv[cmy] ratio. The length density was estimated
for [ima] from Lv[structure] = 2QA[structure] (mm/mm3), QA is the
density per area).
The mean cross-sectional area of the cardiomyocytes was
estimated as A[cmy] = Vv[cmy]/2QA[cmy] (mm2). Where
QA[structure] = N[structure]/AT, N is the number of cmy pro-
ﬁles counted in the test frame, and AT is the test frame area
(considering the forbidden line and its extensions) [25].
2.6. Preparation of cardiac muscle for Western blot analysis
Hearts were quickly excised after killing the animals, and
left ventricles (LVs) were isolated. LVs were then minced and
homogenized on ice with a Polytron for 15 s in a buffer contain-
ing 0.3 M HEPES, 0.5 M EDTA, 0.1 M sodium ﬂuoride, 1 M sodium
pyrophosphate, 0.1 mM sodium orthovanadate, 2% Triton X-100
plus Complete EDTA-Free Protease Inhibitor cocktail tablets (Roche
Diagnostics, California, USA). The homogenates were then cen-
trifuged at 400 × g for 15 min  at 4 ◦C. Pellets were discarded and
supernatants frozen at −20 ◦C.
2.7. ImmunoprecipitationIsolated left ventricules were lysed in 20 mM Tris HCl (pH 7.5),
150 mM NaCl, 5 mM EDTA, 10 mM NaF, 2 mM Na3Vo4, 1% NP-
40, 0.1% SDS, plus Complete EDTA-Free Protease Inhibitor cocktail
l. / Peptides 35 (2012) 65–73 67
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ablets (Roche Diagnostics, California, USA). Lysates (2 g/l) were
ncubated for 2 h at 4 ◦C under rotation with either polyclonal rab-
it anti-PI3-K or polyclonal goat anti-GHSR-1a antibodies (1:200;
anta Cruz Biotechnology, Santa Cruz, CA)) (C-18) Sc-10368. Then,
rotein A/G agarose (20 l/mg protein; Santa Cruz Biotechnology)
as added, and samples were incubated at 4 ◦C overnight. The con-
ent PI3-K and anti-GHSR-1a of was analyzed by Western blotting
s described below.
.8. Western blot analysis
Total protein content in cell extracts was determined by the
CA method (BCATM Protein Assay Kit, Thermo Scientiﬁc, Rockford,
.S.A.). Protein samples were solubilized in Laemmli sample buffer
24] before undergoing to SDS-PAGE. Equal quantities of protein
30 g) were loaded onto 8 or 10% polyacrylamide gels in the pres-
nce of SDS (SDS-PAGE) along with pre-stained molecular weight
tandards (Full Range Rainbow; Amersham Biosciences, UK Lim-
ted). After electrophoretic separation, proteins were transferred
o nitrocellulose membranes (Hybond P; Amersham Biosciences,
K Limited). The membranes were blocked with Tween–TBS (10%
ween 20) containing 5% nonfat dry milk for 1 h and incubated
ith the following primary antibodies overnight: rabbit anti-Akt
/2, rabbit anti-phosphorylated-AKT 1/2/3 (Ser 473), GHSR-1a,
abbit anti-PI3K p85 andactin, from Santa Cruz Biotechnology
USA) and rabbit anti-AMPK rabbit anti-phosphorylated-AMPK(
Thr172) from Upstate Biotechnology, USA. The PVDF ﬁlters were
hen incubated with appropriate secondary antibodies conjugated
o biotin (Santa Cruz Biotechnology), followed by 1-h incubation
ith horseradish peroxidase-conjugated streptavidin (Invitrogen,
amarillo, USA) Immunoreactivity was visualized by enhanced
hemiluminescence (ECL-Plus, Amersham Biosciences, Pittsburgh,
A, USA) and subsequently quantiﬁed by densitometry using Image
 Software (NIH, Bethesda, MD,  USA).
.9. RNA extraction and reverse transcription
RNA was extracted and transcribed into cDNA as described in
50]. Brieﬂy, RNA from left ventricules were isolated using Trizol
xtraction (Invitrogen, Carlsbad, CA, USA) following the manufac-
urer’s protocol. Quantity and quality of the RNA was determined
sing a NanoVue Plus® spectrophotometer (GE Healthcare, USA).
uality of the RNA revealed satisfactory in all cases (260/280 nm
bsorbance ratio between 1.95 and 2.15). RNA recovery from each
issue sample (100 mg)  amounted to approximately 2 g. Here-
fter, equal amounts from the different samples of ampliﬁed RNA
1000 ng) were transcribed into cDNA. The RT reaction was  carried
ut using random primers and Superscript III reverse transcriptase
Invitrogen, Carlsbad, USA), as per manufacturer’s instructions.
.10. Real-time PCR
The real-time RT-PCR reactions were performed using Taq-
an  Universal PCR Master Mix  (Applied BioSystems) in a 20 l
eaction volume containing 50 ng of cDNA. All reactions were per-
ormed in triplicate and included a negative control. PCR reactions
ere performed using an ABI Prism 7500 Sequence Detection Sys-
em (Applied Biosystems). Cycling conditions were: 2 min  at 50 ◦C,
0 min  at 95 ◦C, and 40 cycles of 15 s at 95 ◦C and 1 min  at 60 ◦C. Rela-
ive quantiﬁcation of mRNA levels was obtained by the 7500 system
oftware, which uses the comparative method (CT). Primers and
aqMan probes speciﬁc for GHSR-1a and actin were obtained from
BI TaqMan Gene Expression Assay catalog (Foster City, CA, USA).
his assay comes in a 20× reaction mix, spans an exon–exon junc-
ion, and is optimized to give ∼100% efﬁciency. Ta
b
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Fig. 1. Body weight (g) in SL and NL mice during development from 21 to 180 days
F
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. Statistical analysis
Results are expressed as mean ± S.E.M. The GraphPad Prism 5
rogram (GraphPad softwares, Inc., La Jolla, CA, USA) was  used
or statistical analyses and graphics. Statistical signiﬁcance was
etermined by Student’s t-test for unpaired, bilaterally distributed
alues of equal variance. P < 0.05 was considered statistical signiﬁ-
ant. Statistical analyses of body weight data were conducted using
he Statistical Analysis System (SAS) version 9.1. An analysis of
epeated measurements was conducted using mixed effects (pro-
edure proc mixed in SAS) to test the differences between groups
nd over time.
. Results
.1. Effects of overnutrition during the neonatal suckling period
ver body weight gain
The body weight of SL and NL Swiss mice from the day of birth to
dulthood (180 days of age) were measured. Animals were weighed
eriodically, and our data demonstrated that the SL mice were sig-
iﬁcantly heavier when compared to the NL mice (P < 0.0001) since
he 10th day of life. This difference was higher (P < 0.0001) in all
easured ages until 180 days of age, and persisted, representing
5.6% of weight gain at 180 days of age (Fig. 1). These data was
onﬁrmed to body weight to tibia length ratio where SL presented
igher value than NL group (P < 0.0001) (Table 1).
.2. Effects of overnutrition during the neonatal suckling period
n visceral fat weight and heart size
In accordance with the changes observed in total body weight,
isceral fat weight in SL mice was found to be 78.2% higher relative
ig. 2. Ventral view of the dissected fat pads (bar = 10 mm):  NL group showing diminishe
roup  showing increased retroperitoneal (thin arrow) and genital fat pads (large arrow), of age. Repeated Measures were analyzed by SAS proc mixed, n = 20 animals per
group. *P < 0.05 vs. NL, **P < 0.0001 vs. NL.
to NL at 180 days of age (Fig. 2). Our data also showed that in the SL
mice, heart weight was also increased, and that hearts of SL mice
were 23.5% heavier than those of NL mice. Corroborate with these
results the heart weight to tibia length and left ventricle were also
signiﬁcantly larger in SL than NL mice (P < 0.0001) (Table 1).
d retroperitoneal and genital fat pads, leaving the lumbar muscle (‡)  uncovered. SL
partially covering the kidneys.
G. Lacerda-Miranda et al. / Peptides 35 (2012) 65–73 69
Table  2
Cardiac stereological parameters of normal litter (NL) and small litter (SL) groups at 180 days. Abbreviations: [cmy], cardiomyocytes; [ct], cardiac connective tissue; VV,
volume  density; intramyocardial [ima]; Lv, length density.
Parameters Lv [ima] Vv [ima]/[cmy] VV [ct]
Mean SEM Mean SEM Mean SEM
Normal litter (NL) 1656 80.2 35.0 3.4 11.0 2.5
Small  litter (SL) 535.0* 121.5 10.6* 2.7 21.67* 0.33
Data are mean ± S.E.M. of 8 animals per group.
* P < 0.01 when compared to the NL group.
Fig. 3. Mean cross-sectional area of cardiomyocytes (A[cmy]). Results are expressed
as  mean ± S.E.M., n = 5 animals per group, *P < 0.004 compared to NL group.
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the left ventricles of NL and SL mice (Fig. 7). Fig. 7A shows that
AKT content in SL mice was 42.7% higher when compared to NL
mice (P < 0.03). Furthermore, AKT was  highly phosphorylated in left
ventricles of SL mice (57.1%), when compared to NL mice (Fig. 7B).
F
pThe microscopic parameters of the myocardium were analyzed
nd SL mice displayed cardiomyocyte hypertrophy, as evidenced by
igher cardiomyocyte area (A[cmy]) compared to the NL (P < 0.01)
Fig. 3). Regarding the myocardial vascularization, the results of
he two parameters Lv[ima] and [ima]/[cmy], which are important
easurements to determine myocardial vitality, showed that the
ntramyocardial vessel density was more than 100% minor in the SL
roup (Table 2). The volume density of connective tissue (VV [ct])
as signiﬁcantly greater in SL than in NL group (P < 0.01) (Table 2).
n the myocardial of SL group the cardiomyocyte hypertrophy was
ccompanied to increase of connective tissue and decrease vascu-
arization (Fig. 4).ig. 4. Photomicrographs of left ventricle of NL and SL mice. (A) Normal litter (NL), myo
resence numerous of vessels intramyocardial. (B) Small litter (SL), myocardial hipertrop4.3. Effects of overnutrition during the neonatal suckling period
on liver weight and blood glucose level
There were signiﬁcant effects of overnutrition during the neona-
tal suckling period on liver weight. Table 1 also shows the SL group
had greater liver weights (42.8%) than the matched NL animals
(P < 0.0004). Blood glucose was 34% higher in SL than in NL group
(P < 0.0004).
4.4. Effects of overnutrition during the neonatal suckling period
on ghrelin active levels
To investigate circulating levels of acylated ghrelin, we mea-
sured these after 4 h of fasting. SL group presented signiﬁcantly
decreased plasma acylated ghrelin levels (98.64 ± 23.1 pg/mL)
compared with NL mice (201.1 ± 20.7 pg/mL) (p < 0.01) (Table 1).
4.5. Effects of overnutrition on GHSR-1a and PI3K in left ventricles
Many biological actions of ghrelin are started by the binding of
ghrelin to its cognate cell surface receptor GHSR-1a [53]. SL animals
had a markedly higher (2.9-fold) GHSR-1a content than their coun-
terparts (P < 0.0004) (Fig. 5A and B), and higher PI3K association
with GHSR-1a in SL than NL groups (P < 0.05) (Fig. 5B). In addi-
tion, GHSR-1a mRNA was increased in SL-hearts as compared to
NL ventricles (P < 0.05, Fig. 6).
4.6. Effect of overnutrition during the neonatal suckling period on
AKT content in left ventricles
We  examined the basal phosphorylation state of AKT-Ser473 incardial with normal aspect, intramyocardial arterioles with normal aspect and the
hy, and the presence of inﬂammatory inﬁltrate (large arrows). Bar = 100 m.
70 G. Lacerda-Miranda et al. / Peptides 35 (2012) 65–73
F mun
a nti-PI3
a P < 0.0
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gig. 5. GHSR-1a content and phosphorylation in left ventricles of NL and SL mice. Im
nd  Western blotting analysis was probed with anti-GHSR-1a (A, lower panel) and a
s  arbitrary units. Results are expressed as mean ± S.E.M., n = 5 animals per group, *
.7. Effect of overnutrition during the neonatal suckling period on
MPK content in left ventriclesWe investigated AMPK content and activation. Fig. 8(A and B),
hows that there were no signiﬁcant difference among the groups
ith respect to AMPK content and phosphorylation.
ig. 6. Expression of GHSR-1a mRNA by Real Time PCR. RNA was  prepared from
yocardial tissues and subsided to quantitative RT-PCR (duplicate determinations).
ata were calculated relative to actin mRNA using an efﬁciency-corrected algorithm.
elative expression ratio of ghrelin receptor mRNA in NL vs. SL, mean ± SEM, n = 5
nimals per group. Statistical signiﬁcance was obtained by unpaired t test. Results
re expressed as mean ± S.E.M., n = 5 animals per group, *P < 0.05 compared to NL
roup.oprecipitation was performed with anti-GHSR-1a antibody (A and B, upper panel),
K antibodies (B, lower panel). The results of scanning densitometry were expressed
04 compared to NL group.
5. Discussion
Early life overnutrition induced a signiﬁcant increase in body
weight in adult mice. This observation conﬁrms previous results
from our and other groups [9,26,28,35,37]. Basically, obesity
resulted in a signiﬁcant accumulation of retroperitoneal and epi-
didymal fat masses when the mice reach adulthood. In addition, we
observed increased ratio of body weight to tibia length in early life
overnourished mice, showing that the difference between groups
was in body weight, not in length. In others words, early life over-
nutrition induced a metabolic proﬁle where energy storage was
privileged. Thus, these data reinforces the theory that the develop-
ment of obesity, diabetes, and cardiovascular disease is an expected
output in adulthood of the animals submitted to disturbed nutrition
in early life [9,26,28,35,37,45].
Therefore, we  hypothesized that in hearts of these obese mice,
the signaling process of the gut-derived hormone ghrelin should
be altered. In this context to explain this process we  ﬁrstly showed
the presence of the ghrelin receptor GHSR-1a in left ventricles con-
ﬁrming results from other authors [8].  And, as original data, we
clearly demonstrated that obesity induced in early life increases
heart ghrelin receptor expression (GHSR-1a) in adulthood. In other
words, these result conﬁrmed evidences indicating that cardiovas-
cular tissue is rich in ghrelin receptors, reinforcing results in the
literature in which increases are found in ghrelin receptor mRNA
of human cardiomyocytes, rat cardiomyocytes and cardiovascular
vessels [13]. In this context, a recent clinical study showed that
the myocardial expression of ghrelin and ghrelin receptor GHSR-
1a, were different in atria and ventricle of patients with congestive
heart failure (CHF) [29]. In fact, ghrelin effect can decrease periph-
eral vascular resistance, resulting in an increase in cardiac index
and stroke volume.
Results from the literature concerning plasma ghrelin are con-
troversial. For instance, Iglesias et al. [16], documented elevated
circulating levels of ghrelin in patients presenting heart failure
independently of their body mass index in contrast to the data of
Nagaya et al. [29], who  demonstrated elevated levels of ghrelin only
in cachectic patients with heart failure. Therefore, the impaired
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Fig. 7. Western blot analysis of total Akt content and phosphorylation in left ventricles of NL and SL mice. Tissue extracts were immunoblotted with anti-Akt antibody (A
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ower acylated plasma ghrelin in these obese mice. In others words,
he increased GHSR-1a expression founded in SL might be regarded
s an underlying mechanism to compensate the decreased hor-
one action.
Nevertheless, beyond altered levels of the hormone, changes
n hormone signaling may  be used as an adaptative factor during
eart new challenges. The increased activation of GHSR-1a should
e followed by a corresponding increasing in proteins involved in
ormone signaling to ensure the augmented sensitivity of the sys-
em. Therefore, we hypothesized that disturbed or new association
f the ghrelin receptor and signaling processes in these hearts may
e observed throughout the study of three key proteins involved in
his process: AMPK, PI3K and AKT. Our data conﬁrmed this associa-
ion. We  showed that the ampliﬁed GHSR-1a expression in cardiac
eft ventricles of SL mice was directly associated with an elevated
ontent and activation of PI3K and AKT pathway but not AMPK.
he physiological importance of the above dissociation between
KT/AMPK remains in the fact that in normal hearts the activation
f AMPK by ischemia is an important protective agent against apop-
otic activity associated with ischemia and reperfusion [39]. These
esults reinforced previous studies where this synergism between
I3K/AKT leads to pathological hypertrophy in a long term [44].
AMPK plays an important role in the metabolism of glucose,
roducing the majority of ATP, second to the fatty acid oxida-
ion in heart [31]. The targets of phosphorylation by AMPK and
ts mediators are diverse, protein kinase C (PKC), p38 mitogen-
ctivated protein kinase or binding protein complex 1 [17,41].
MPK phosphorylates the 6-phosphofructo-2-kinase (PFK 2), to
ctivate glycolysis during states of myocardial ischemia, exercise
nd anoxia, this activation is competitively regulated [1,15,43,54].
n this context, our ﬁndings showed a high glucose concentration
n obese mice after post natal hypernutrition. Similarly with recent
tudy where this result was regard as a prediabetic state which
ould be offer one ﬁrst explanation of the process [21], it is possible
o suggest that high glucose may  acts as a inhibition factor of AMPK
ctivity in all tissues studied, including heart [40]. Studies showed
hat the effects of AMPK on glycemia are highly complex as a result
f isoform- and tissue-speciﬁc functions simultaneous modulation
f its activity in different tissues can have opposing effects on glu-
ose homeostasis [12,42].  Despite the fact that more studies are
ecessary, our results showing that AMPK was not associated to
HSR-1a activation, raised the possible suggestion which is the
yperglycemia found in these mice may  works as an inhibitory fac-
or against the AMPK increasing activity. For instance, other authors
ave not succeeded in observing a ghrelin effect on AMPK activity
n muscle [3,23].
In conclusion, early life overnutrition induces obesity and
yocardial remodeling associated with decreased ghrelin level and
ncreased GHS-R1a, PI3K, AKT but not AMPK in adult mice. These
esults suggest that ghrelin in obesity is related to alterations of
ardiac metabolism through cell growth (AKT and PI3K) and cell
nergy ﬂow (AMPK).
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